Pfizer Reports No Major Issues After Expanding Trial to 44,000 People; Vaccine Looks “Safe”
2 Mins read
Pfizer has said that its candidate vaccine for COVID-19 looks potentially safe. The company believes it will have the necessary data on the vaccine’s efficacy by next month.